ASSOCIATION OF HIGH LIPOPROTEIN(a) LEVELS WITH CORONARY ARTERY PATENCY DURING THE FIRST YEAR AFTER PERCUTANEOUS CORONARY INTERVENTIONS

ASSOCIATION OF HIGH LIPOPROTEIN(a) LEVELS WITH CORONARY ARTERY PATENCY DURING THE FIRST YEAR AFTER PERCUTANEOUS CORONARY INTERVENTIONS

Show other versions (1)

<p><strong>Objective:</strong> to study an association of high lipoprotein(a) [Lp(a)] levels with the development of restenosis and the progression of coronary<br />atherosclerosis after percutaneous coronary interventions (PCI) in patients with chronic coronary heart disease...

Full description

Bibliographic Details
Main Authors:	M. V. Ezhov, M. S. Safarova, Yu. G. Matchin, D. I. Soboleva, O. I. Afanasyeva, S. N. Pokrovsky
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	coronary heart disease risk factors lipoprotein(a) percutaneous coronary interventions progression of atherosclerosis restenosis
Online Access:	http://klinitsist.abvpress.ru/index.php/Klin/article/view/132

Similar Items

ASSOCIATION OF HIGH LIPOPROTEIN(a) LEVELS WITH CORONARY ARTERY PATENCY DURING THE FIRST YEAR AFTER PERCUTANEOUS CORONARY INTERVENTIONS
by: M. V. Ezhov, et al.
Published: (2014-07-01)

Correlation Between Lipoprotein(a) and Prognosis for Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention
by: Azhi ShaMa, MM, et al.
Published: (2024-12-01)

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
by: Waseem Raja, et al.
Published: (2020-12-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

Lipoprotein (a) polymorphism as a risk factor of coronary and carotid atherosclerosis and its complications in women
by: O. I. Afanasyeva, et al.
Published: (2010-12-01)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
by: Huilin Hu, et al.
Published: (2021-11-01)

Impact of coronary artery calcification on percutaneous coronary intervention and postprocedural complications
by: Rami M. Abazid, et al.
Published: (2017-01-01)

Long-Term Angiographic Results of Recanalization of Small Diameter Coronary Arteries in Patients with Coronary Heart Disease
by: E. V. Aksenov, et al.
Published: (2021-06-01)

Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Erkan Yıldırım, et al.
Published: (2017-12-01)

Coronary CT Angiography- Based Assessment of Coronary in-Stent Restenosis: A Journey through Past and Present Trends
by: Yoon Seong Lee, et al.
Published: (2024-03-01)

Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention
by: Wenbo He, et al.
Published: (2021-09-01)

Risk factors,pathogenic mechanisms and treatment progress of coronary in-stent restenosis
by: Zha Lingfeng, et al.
Published: (2024-09-01)

In-Stent Restenosis Overview: From Intravascular Imaging to Optimal Percutaneous Coronary Intervention Management
by: Neda Shafiabadi Hassani, et al.
Published: (2024-03-01)

Plasma apelin level after percutaneous coronary intervention
by: Ayman Ahmed Abdelaziz, et al.
Published: (2015-03-01)

Thrombosis prevention in percutaneous coronary interventions
by: V. P. Lupanov, et al.
Published: (2009-08-01)

Recurrent ischemia after percutaneous coronary intervention
by: M. P. Malgina, et al.
Published: (1970-01-01)

Influence of remnant lipoprotein particle cholesterol on non-target lesions progression in patients undergoing percutaneous coronary intervention
by: Jing Liu, et al.
Published: (2024-12-01)

Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study
by: Ling Zhang, et al.
Published: (2021-09-01)

Outcomes of Percutaneous Coronary Intervention for In‐Stent Restenosis Versus De Novo Lesions: A Meta‐Analysis
by: Ayman Elbadawi, et al.
Published: (2023-07-01)

The role of atherosclerosis risk factors in development of coronary artery disease in young men
by: M V Ezhov, et al.
Published: (2009-05-01)

Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention
by: Jiqiang Guo, et al.
Published: (2022-05-01)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
by: Zhihao Chen, et al.
Published: (2018-11-01)

'Miracle stents' - a future without restenosis
by: Huda Hamid, et al.
Published: (2020-12-01)

Electrospun bioresorbable polymer membranes for coronary artery stents
by: Maria A. Rezvova, et al.
Published: (2024-08-01)

Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis
by: Hyung Joon Joo, et al.
Published: (2018-06-01)

Adjustment for Atherosclerosis Diagnosis Distorts the Effects of Percutaneous Coronary Intervention and the Ranking of Hospital Performance
by: Bijan A. Niknam, et al.
Published: (2018-06-01)

Three-dimensional assessment of coronary high-intensity plaques with T1-weighted cardiovascular magnetic resonance imaging to predict periprocedural myocardial injury after elective percutaneous coronary intervention
by: Hayato Hosoda, et al.
Published: (2020-01-01)

IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01)

Effect of Epicardial Adipose Tissue on In-stent Restenosis after Percutaneous Coronary Intervention: a Review
by: AN Jingjing, WANG Xiaojuan, DENG Aiyun
Published: (2023-03-01)

Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting for Treating In-Stent Restenosis in Unprotected-Left Main: LM-DRAGON-Registry
by: Wojciech Wańha, et al.
Published: (2022-04-01)

Predicting Cardiovascular Outcomes by Baseline Lipoprotein(a) Concentrations: A Large Cohort and Long‐Term Follow‐up Study on Real‐World Patients Receiving Percutaneous Coronary Intervention
by: Hui‐Hui Liu, et al.
Published: (2020-02-01)

Relationship between ALDH2 genotype and in-stent restenosis in Chinese Han patients after percutaneous coronary intervention
by: Lizhi Lv, et al.
Published: (2019-07-01)

Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study
by: Zheng Qin, et al.
Published: (2019-01-01)

Prognostic Impacts of Comorbid Significant Coronary Stenosis and Coronary Artery Spasm in Patients With Stable Coronary Artery Disease
by: Kiyotaka Hao, et al.
Published: (2021-01-01)

A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents
by: Min-Tao Gai, et al.
Published: (2021-09-01)

Stabilization of a slipping balloon during the treatment of in-stent severe restenosis - anchoring the balloon shaft in the guiding catheter
by: Ali Rıza Akyüz, et al.
Published: (2014-06-01)

Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention
by: Long Chen, et al.
Published: (2021-06-01)

Percutaneous Coronary Intervention for Coronary Arteries with Origin and Course Anomalies: Case Reports and Literature Review
by: Murat Akcay, et al.
Published: (2019-06-01)

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions
by: Yu. A. Shuvalova, et al.
Published: (2007-10-01)

Outcome of coronary angiography and percutaneous coronary intervention in Egyptian women with chronic stable angina
by: Mazen Tawfik, et al.
Published: (2011-03-01)